Mast Therapeutics, Inc. (MSTX) to Present MST-188 Data at ASH

November 17, 2014 8:12 AM EST Send to a Friend
Mast Therapeutics, Inc. (NYSE: MSTX), a clinical-stage biopharmaceutical company, today announced that it will be presenting data from an ex ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login